Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia

J. F. Seymour*, T. J. Kipps, B. Eichhorst, P. Hillmen, J. D'Rozario, S. Assouline, C. Owen, J. Gerecitano, T. Robak, J. De La Serna, U. Jaeger, G. Cartron, M. Montillo, R. Humerickhouse, E. A. Punnoose, Y. Li, M. Boyer, K. Humphrey, M. Mobasher, A. P. Kater

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    730 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science